Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Some chemotherapy can cause permanent hair loss.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Improving the environment and cell interactions is key for creating human hair in the lab.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

Vitamin D3 can help improve hair growth by enhancing the function of specific skin cells and could be useful in hair regeneration treatments.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.